(R)-2-((2-Ethoxyphenoxy)methyl)morpholine hydrochloride, 98.0%, 25mg

3-(Aminomethyl)-4-methoxyaniline dihydrochloride, 95.0%, 1g

(1S)-7-CHLORO-1,2,3,4-TETRAHYDRONAPHTHYLAMINE, 95.0%, 100mg

2-Methyl-2H-indazole, 95.0%, 5g

4-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 95%, 250mg

N-Ethyl-o-toluidine>98.0%(GC)(T)25mL

Labels Tough Spots on the roll round, yellow, 9.5 mm, Gesch. for, 0.5 ml vials, 1 Roll

4-Chlorostyrene (stabilised with TBC), 99.00%, 5g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridin-2-amine, 98%, 1g

1-(6-(Trifluoromethyl)pyridin-3-yl)cyclopropane-1-carboxylic acid, 98%, 100mg

N,N,N',N'-Tetramethylethylenediamine [for Electrophoresis]>98.0%(GC)(T)5g

2,4-Difluoroanisole, 98.0%, 25g

(S)-2-Amino-3-(3,5-dichlorophenyl)propanoic acid, 95.0%, 5g